Candriam Luxembourg S.C.A. Makes New $99,000 Investment in Aurora Cannabis Inc. (NYSE:ACB)

Candriam Luxembourg S.C.A. purchased a new position in Aurora Cannabis Inc. (NYSE:ACB) during the 3rd quarter, HoldingsChannel.com reports. The firm purchased 14,354 shares of the company’s stock, valued at approximately $99,000.

A number of other institutional investors have also bought and sold shares of ACB. Advisory Services Network LLC acquired a new position in Aurora Cannabis in the second quarter worth approximately $35,000. Aurora Private Wealth Inc. grew its position in Aurora Cannabis by 19.2% in the third quarter. Aurora Private Wealth Inc. now owns 11,918 shares of the company’s stock worth $82,000 after buying an additional 1,917 shares during the last quarter. Kestra Advisory Services LLC acquired a new position in Aurora Cannabis in the third quarter worth approximately $93,000. HighTower Advisors LLC acquired a new position in Aurora Cannabis in the second quarter worth approximately $95,000. Finally, Cresset Asset Management LLC purchased a new position in Aurora Cannabis during the 2nd quarter worth approximately $99,000. Hedge funds and other institutional investors own 17.24% of the company’s stock.

Several equities analysts have weighed in on the stock. Zacks Investment Research cut shares of Aurora Cannabis from a “hold” rating to a “sell” rating in a research report on Tuesday. CIBC upgraded shares of Aurora Cannabis from an “underperform” rating to a “neutral” rating in a research report on Wednesday, November 10th. Jefferies Financial Group reissued a “hold” rating on shares of Aurora Cannabis in a research note on Friday, October 1st. Cantor Fitzgerald reduced their price objective on shares of Aurora Cannabis from C$12.00 to C$8.30 and set a “neutral” rating for the company in a research note on Friday, September 17th. Finally, MKM Partners raised shares of Aurora Cannabis from a “sell” rating to a “neutral” rating and lifted their price objective for the company from $6.00 to $7.00 in a research note on Tuesday, September 28th. Five analysts have rated the stock with a sell rating and seven have issued a hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $7.08.

Aurora Cannabis stock opened at $5.51 on Friday. The company has a debt-to-equity ratio of 0.18, a current ratio of 5.42 and a quick ratio of 4.13. Aurora Cannabis Inc. has a fifty-two week low of $5.22 and a fifty-two week high of $18.98. The firm has a fifty day moving average price of $6.31 and a two-hundred day moving average price of $6.87.

Aurora Cannabis (NYSE:ACB) last released its earnings results on Tuesday, November 9th. The company reported ($0.09) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.18) by $0.09. The firm had revenue of $47.74 million during the quarter, compared to analyst estimates of $47.84 million. Aurora Cannabis had a negative net margin of 252.40% and a negative return on equity of 9.09%. Analysts forecast that Aurora Cannabis Inc. will post -0.61 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis, Inc engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Recommended Story: Margin

Want to see what other hedge funds are holding ACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aurora Cannabis Inc. (NYSE:ACB).

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.